PET/CT with 3'-deoxy-3'-[18F]fluorothymidine for lung cancer patients receiving carbon-ion radiotherapy

Nuclear Medicine Communications

Volumn 32, Issue 5, 2011, Pages 348-355

  Saga, Tsuneo ^a   Koizumi, Mitsuru ^a   Inubushi, Masayuki ^a   Yoshikawa, Kyosan ^c   Tanimoto, Katsuyuki ^c   Fukumura, Toshimitsu ^b   Miyamoto, Tadaaki ^c   Nakajima, Mio ^c   Yamamoto, Naoyoshi ^c   Baba, Masayuki ^c  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b Molecular Imaging Center   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

carbon ion radiotherapy; F 18 fluorothymidine; lung cancer; positron emission tomography

Indexed keywords

3' FLUOROTHYMIDINE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG TUMOR LEVEL; FEMALE; FOLLOW UP; HUMAN; ION THERAPY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION PNEUMONIA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARBON; DIDEOXYNUCLEOSIDES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 79955010693     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328344a427     Document Type: Article

References (32)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70. (Pubitemid 30046295)
2. Eary JF, Mankoff DA, Spence AM, Berger MS, Olshen A, Link JM, et al. 2-[C-11]thymidine imaging of malignant brain tumors. Cancer Res 1999; 59:615-621. (Pubitemid 29076059)
3. Shields AF, Grierson JR, Dohmen BM, Machulla HJ, Stayanoff JC, Lawhorn-Crews JM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998; 4:1334-1336. (Pubitemid 28512118)
4. 18F]FLT-PET in oncology: current status and opportunities. Eur J Nucl Med Mol Imaging 2004; 31:1659-1672. (Pubitemid 40104613)
5. Bading JR, Shields AF. Imaging of cell proliferation: status and prospects. J Nucl Med 2008; 49 (Suppl 2):64S-80S. (Pubitemid 351948037)
6. 18F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res 2002; 8:3315-3323. (Pubitemid 35340704)
7. 18F-FDG. J Nucl Med 2003; 44:1426-1431. (Pubitemid 39663355)
8. 18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors. Eur J Nucl Med Mol Imaging 2005; 32:653-659.
9. Saga T, Kawashima H, Araki N, Takahashi JA, Nakashima Y, Higashi T, et al. Evaluation of primary brain tumors with FLT-PET: usefulness and limitations. Clin Nucl Med 2006; 31:774-780. (Pubitemid 44789556)
10. Buck AK, Bommer M, Stilgenbauer S, Juweid M, Glatting G, Schirrmeister H, et al. Molecular imaging of proliferation in malignant lymphoma. Cancer Res 2006; 66:11055-11061. (Pubitemid 44877006)
11. 18F-3'-fluoro-3'-deoxy-L-thymidine. Clin Cancer Res 2004; 10:1685-1690. (Pubitemid 38435559)
12. 18F-fluorothymidine. J Nucl Med 2009; 50:1441-1447.
13. 18F]fluorothymidine posi-tron emission tomography. Eur J Nucl Med Mol Imaging 2007; 34:1339-1347. (Pubitemid 47312585)
14. 18F]fluorothymidine- positron emission tomography in high-grade non-Hodgkin's lymphoma. Clin Cancer Res 2007; 13:3552-3558. (Pubitemid 46955115)
15. 18F]Fluorothymidine positron emission tomography before and 7 days after gefitinib treatment predicts response in patients with advanced adenocarcinoma ofthe lung. Clin Cancer Res 2008; 14:7423-7429.
16. 18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer. Eur J Nucl Med Mol Imaging 2007; 34:878-883. (Pubitemid 46798949)
17. Miyamoto T, Yamamoto N, Nishimura H, Koto M, Tsujii H, Mizoe JE, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother Oncol 2003; 66:127-140. (Pubitemid 36315822)
18. Miyamoto T, Baba M, Sugane T, Nakajima M, Yashiro T, Kagei K, et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2007; 2:916-926. (Pubitemid 47511595)
19. Schulz-Ertner D, Tsujii H. Particle radiation therapy using proton and heavier ion beams. J Clin Oncol 2007; 25:953-964. (Pubitemid 350002861)
20. Kanai T, Matsufuji N, Miyamoto T, Mizoe J, Kamada T, Tsuji H, et al. Examination of GyE system for HIMAC carbon therapy. Int J Radiat Oncol Biol Phys 2006; 64:650-656. (Pubitemid 43083456)
21. 18F] FLT. Nucl Med Biol 2002; 29:263-273. (Pubitemid 34127960)
22. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: recised RECIST guideline (version 1.1). Eur J Cancer 2009; 45:228-247.
23. Koizumi M, Saga T, Yoshikawa K, Baba M. Gastric cancer found on 3'-deoxy-3' F-18 fluorothymidine positron emission tomography. Clin Nucl Med 2008; 33:641-642.
24. Koizumi M, Saga T, Inubushi M, Fukumura T, Yoshikawa Y, Yamamoto N, et al. Uptake decrease of proliferative PET tracer F-18 FLT in bone marrow after carbon ion therapy in lung cancer. Mol Imaging Biol 2010; (in press).
25. 11C-methionine PET for evaluation of treatment response of lung cancer after stereotactic radiotherapy. Ann Nucl Med 2004; 18:669-674. (Pubitemid 40215915)
26. 18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol 2007; 25:3116-3123. (Pubitemid 47218060)
27. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients. J Nucl Med 2007; 48:726-735. (Pubitemid 47604972)
28. Abratt RP, Morgan GW. Lung toxicity following chest irradiation in patients with lung cancer. Lung Cancer 2002; 35:103-109. (Pubitemid 34136086)
29. Marks LB, Yu X, Vujaskovic Z, Small W Jr, Folz R, Anscher MS. Radiation-induced lung injury. Semin Radiat Oncol 2003; 13:333-345. (Pubitemid 36966158)
30. Buck AK, Hetzel M, Schirrmeister H, Halter G, Möller P, Kratochwil C, et al. Clinical relevance of imaging proliferative activity in lung nodules. Eur J Nucl Med Mol Imaging 2005; 32:525-533. (Pubitemid 41214194)
31. 18F-fluoro-deoxyglucose-positron emission tomography. Chest 2006; 129:393-401. (Pubitemid 43289860)
32. 11C]-methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy. Clin Cancer Res 2004; 10:1764-1772. (Pubitemid 38443328)